EGRX
Eagle Pharmaceuticals Inc
Price:  
6.48 
USD
Volume:  
188,228.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EGRX WACC - Weighted Average Cost of Capital

The WACC of Eagle Pharmaceuticals Inc (EGRX) is 7.7%.

The Cost of Equity of Eagle Pharmaceuticals Inc (EGRX) is 11.25%.
The Cost of Debt of Eagle Pharmaceuticals Inc (EGRX) is 5.05%.

Range Selected
Cost of equity 9.60% - 12.90% 11.25%
Tax rate 39.20% - 44.10% 41.65%
Cost of debt 4.70% - 5.40% 5.05%
WACC 6.7% - 8.7% 7.7%
WACC

EGRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.25 1.44
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.60% 12.90%
Tax rate 39.20% 44.10%
Debt/Equity ratio 0.74 0.74
Cost of debt 4.70% 5.40%
After-tax WACC 6.7% 8.7%
Selected WACC 7.7%